Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis

Journal of Rheumatology

Volumn 38, Issue 8, 2011, Pages 1617-1621

  Bernardo, Pasquale ^a   Conforti, Maria Letizia ^a   Bellando Randone, Silvia ^a   Pieragnoli, Paolo ^a   Blagojevic, Jelena ^a   Kaloudi, Olga ^a   Guiducci, Serena ^a   Porta, Francesco ^a   Padeletti, Luigi ^a   Gensini, Gian Franco ^a   Matucci Cerinic, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Implantable cardioverter defibrillator; Sudden cardiac death; Systemic sclerosis; Ventricular tachyarrhythmias

Indexed keywords

AMIODARONE; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CLOPIDOGREL; DILTIAZEM; FLECAINIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEFIBRILLATION; DEFIBRILLATOR; DISEASE ASSOCIATION; ELECTRIC SHOCK; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SUDDEN DEATH; SYSTEMIC SCLEROSIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; TACHYCARDIA, VENTRICULAR;

EID: 78649379541     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100480     Document Type: Article

References (17)

1. Guiducci S, Giacomelli R, Matucci-Cerinic M. Vascular complications of scleroderma. Autoimmune Rev 2007;6:520-3. (Pubitemid 47374612)
2. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology 2006;45 Suppl:14-7.
3. Bukley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976;53:483-90.
4. Kostis JB, Seibold JR, Turkevich D, Masi AT, Grau RG, Medsger TA, et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med 1988;84:1007-15.
5. James TN. De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease. Circulation 1974;50:844-56.
6. Anvari A, Granger W, Schneder B, Sochor H, Weber H, Schmidinger H. Cardiac involvement in systemic sclerosis. Arthritis Rheum 1992;35:1356-61.
7. Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, et al. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with antitopoisomerase I antibody. Arthritis Rheum 2007;56:2740-6. (Pubitemid 47237293)
8. Clements PJ, Furst DE, Cabeen W, Tashkin D, Paulus HE, Roberts N. The relationship of arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis. Am J Med 1981;71:38-46. (Pubitemid 12254711)
9. Wranicz J, Zielinska M, Cygankiewicz I, Dziankowska-Bartkowiak B, Sysa-Jedrzejowska A. Early cardiovascular involvement in patients with systemic sclerosis (SSc). Med Sci Monit 2002;8:CR78-82. (Pubitemid 34218461)
10. Martinez-Taboada V, Olalla J, Blanco R, Armona J, Sueiro JF, Rodriguez-Valverde V. Malignant ventricular arrhythmia in systemic sclerosis controlled with an implantable cardioverter defibrillator. J Rheumatol 1994;21:2166-7. (Pubitemid 24352373)
11. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
12. Pignone A, Scaletti C, Matucci-Cerinic M, Vàzquez-Abad D, Meroni PL, Del Papa N, et al. Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. Clin Exp Rheumatol 1998;16:527-32. (Pubitemid 28439433)
13. Rankin AC, Osswald S, McGovern BA, Ruskin JN, Garan H. Mechanism of sustained monomorphic ventricular tachycardia in systemic sclerosis. Am J Cardiol 1999;83:633-6. (Pubitemid 29097976)
14. Gallagher JJ, Anderson RW, Kasell J, Rice JR, Pritchett EL, Gault HJ, et al. Cryoablation of drug-resistant ventricular tachycardia in a patient with a variant of sclerodema. Circulation 1978;57:190-7. (Pubitemid 8254698)
15. Long A, Duffy G, Bresnihan B. Reversible myocardial perfusion defects during cold challenge in scleroderma. Br J Rheumatol 1986;25:158-61. (Pubitemid 16033795)
16. Follansbee WP, Zerbe TR, Medsger TA Jr. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993;125:194-203. (Pubitemid 23021644)
17. Passman R, Kadish A. Sudden death prevention with implantable devices. Circulation 2007;116:561-71. (Pubitemid 47454479)